Kala Pharmaceuticals (KALA) PT Lowered to $8 at BofA Securities
Tweet
Share
E-mailGet Alerts KALA Hot Sheet
Price: $0.56 +7.69%
Rating Summary:
5 Buy, 5 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 5 | Down: 18 | New: 28
Rating Summary:
5 Buy, 5 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 5 | Down: 18 | New: 28
Join SI Premium – FREE
BofA Securities analyst Tazeen Ahmad lowered the price target on Kala Pharmaceuticals (NASDAQ: KALA) to $8.00 (from $10.00) while maintaining a Buy rating.
You May Also Be Interested In
- Kala Bio signs exclusive U.S. deal to distribute Virotek eye genetic tests
- Climb Bio (CLYM) PT Raised to $32 at BTIG
- JPMorgan Downgrades Inpex Corp (1605:JP) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
